2016 - 2020

A 3D-printed biomaterials-based platform to advance established therapy avenues against primary bone cancers.

Lahr CA, Landgraf M, Sanchez-Herrero A, Dang HP, Wagner F, Bas O, Bray LJ, Tran P, Holzapfel BM, Shafiee A, McGovern JA, Hutmacher DW

Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR.

Berthold F, Faldum A, Ernst A, Boos J, Dilloo D, Eggert A, Fischer M, Frühwald M, Henze G, Klingebiel T, Kratz C, Kremens B, Krug B, Leuschner I, Schmidt M, Schmidt R, Schumacher-Kuckelkorn R, von Schweinitz D, Schilling FH, Theissen J, Volland R, Hero B, Simon T

High expression of IGF2-derived intronic miR-483 predicts outcome in hepatoblastoma.

Weiss JBW, Wagner AE, Eberherr C, Häberle B, Vokuhl C, von Schweinitz D, Kappler R

Age-Dependent Presentation and Clinical Course of 1465 Patients Aged 0 to Less than 18 Years with Ovarian or Testicular Germ Cell Tumors; Data of the MAKEI 96 Protocol Revisited in the Light of Prenatal Germ Cell Biology.

Calaminus G, Schneider DT, von Schweinitz D, Jürgens H, Infed N, Schönberger S, Olson TA, Albers P, Vokuhl C, Stein R, Looijenga L, Sehouli J, Metzelder M, Claviez A, Dworzak M, Eggert A, Fröhlich B, Gerber NU, Kratz CP, Faber J, Klingebiel T, Harms D, Göbel U

SP8 Promotes an Aggressive Phenotype in Hepatoblastoma via FGF8 Activation.

Wagner AE, Schwarzmayr T, Häberle B, Vokuhl C, Schmid I, von Schweinitz D, Kappler R

A new parameter for the management of positional plagiocephaly: the size of the anterior fontanelle matters.

Wendling-Keim DS, Macé Y, Lochbihler H, Dietz HG, Lehner M

On-site CAD templates reduce surgery time for complex craniostenosis repair in infants: a new method.

Lehner M, Wendling-Keim D, Kunz M, Deininger S, Zundel S, Peraud A, Mast G

A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients.

Cairo S, Armengol C, Maibach R, Häberle B, Becker K, Carrillo-Reixach J, Guettier C, Vokuhl C, Schmid I, Buendia MA, Branchereau S, von Schweinitz D, Kappler R

Team performance during postsurgical patient handovers in paediatric care.

Weigl M, Heinrich M, Keil J, Wermelt JZ, Bergmann F, Hubertus J, Hoffmann F

Outcome of Patients With Esophageal Atresia and Very Low Birth Weight (≤ 1,500 g).

Ritz LA, Widenmann-Grolig A, Jechalke S, Bergmann S, von Schweinitz D, Lurz E, Hubertus J

Prophylactic Drain Placement in Childhood Perforated Appendicitis: Does Spillage Matter?

Schmidt YM, Wendling-Keim D, von Schweinitz D, Hubertus J, Berger M

SOX9 Knockout Induces Polyploidy and Changes Sensitivity to Tumor Treatment Strategies in a Chondrosarcoma Cell Line.

Stöckl S, Lindner G, Li S, Schuster P, Haferkamp S, Wagner F, Prodinger PM, Multhoff G, Boxberg M, Hillmann A, Bauer RJ, Grässel S

Local Stage Dependent Necessity of Radiation Therapy in Rhabdoid Tumors of the Kidney (RTK).

Melchior P, Dzierma Y, Rübe C, Graf N, Kager L, Dieckmann K, Kroiss S, Hubertus J, Warmann S, Schenk JP, Leuschner I, Nemes K, Meier CM, Vokuhl C, Frühwald M, Furtwängler R

The PROCESS 2020 Guideline: Updating Consensus Preferred Reporting Of CasESeries in Surgery (PROCESS) Guidelines.

Agha RA, Sohrabi C, Mathew G, Franchi T, Kerwan A, O'Neill N, PROCESS Group

The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines.

Agha RA, Franchi T, Sohrabi C, Mathew G, Kerwan A, SCARE Group

Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.

Regel I, Eichenmüller M, Mahajan UM, Hagl B, Benitz S, Häberle B, Vokuhl C, von Schweinitz D, Kappler R

Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.

Carrillo-Reixach J, Torrens L, Simon-Coma M, Royo L, Domingo-Sàbat M, Abril-Fornaguera J, Akers N, Sala M, Ragull S, Arnal M, Villalmanzo N, Cairo S, Villanueva A, Kappler R, Garrido M, Guerra L, Sábado C, Guillén G, Mallo M, Piñeyro D, Vázquez-Vitali M, Kuchuk O, Mateos ME, Ramírez G, Santamaría ML, Mozo Y, Soriano A, Grotzer M, Branchereau S, García de Andoin N, López-Ibor B, López-Almaraz R, Salinas JA, Torres B, Hernández F, Uriz JJ, Fabre M, Blanco J, Paris C, Bajčiová V, Laureys G, Masnou H, Clos A, Belendez C, Guettier C, Sumoy L, Planas R, Jordà M, Nonell L, Czauderna P, Morland B, Sia D, Losic B, Buendia MA, Sarrias MR, Llovet JM, Armengol C

Current Treatment of Esophageal Atresia with Tracheoesophageal Fistula - Updated Guidelines of the German Society of Pediatric Surgery.

Mayer S, Gitter H, Göbel P, Hirsch FW, Höhne C, Hosie S, Hubertus J, Leutner A, Muensterer O, Schmittenbecher P, Seidl E, Stepan H, Thome U, Till H, Widenmann-Grolig A, Lacher M

Human exome and mouse embryonic expression data implicate ZFHX3, TRPS1, and CHD7 in human esophageal atresia.

Zhang R, Gehlen J, Kawalia A, Melissari MT, Dakal TC, Menon AM, Höfele J, Riedhammer K, Waffenschmidt L, Fabian J, Breuer K, Kalanithy J, Hilger AC, Sharma A, Hölscher A, Boemers TM, Pauly M, Leutner A, Fuchs J, Seitz G, Ludwikowski BM, Gomez B, Hubertus J, Heydweiller A, Kurz R, Leonhardt J, Kosch F, Holland-Cunz S, Münsterer O, Ure B, Schmiedeke E, Neser J, Degenhardt P, Märzheuser S, Kleine K, Schäfer M, Spychalski N, Deffaa OJ, Gosemann JH, Lacher M, Heilmann-Heimbach S, Zwink N, Jenetzky E, Ludwig M, Grote P, Schumacher J, Thiele H, Reutter H

The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database.

Haeberle B, Rangaswami A, Krailo M, Czauderna P, Hiyama E, Maibach R, Lopez-Terrada D, Aronson DC, Alaggio R, Ansari M, Malogolowkin MH, Perilongo G, O'Neill AF, Trobaugh-Lotrario AD, Watanabe K, Schmid I, von Schweinitz D, Ranganathan S, Yoshimura K, Hishiki T, Tanaka Y, Piao J, Feng Y, Rinaldi E, Saraceno D, Derosa M, Meyers RL

A humanized bone microenvironment uncovers HIF2 alpha as a latent marker for osteosarcoma.

Wagner F, Holzapfel BM, Martine L, McGovern J, Lahr CA, Boxberg M, Prodinger PM, Grässel S, Loessner D, Hutmacher DW

A Knee Size-Independent Parameter for Malalignment of the Distal Patellofemoral Joint in Children.

Wagner F, Maderbacher G, Matussek J, Holzapfel BM, Kammer B, Hubertus J, Anders S, Winkler S, Grifka J, Keshmiri A

Activation of Hedgehog Signaling in AggressiveHepatic Hemangioma in Newborns and Infants

Wendling-Keim D, Vokuhl C, Walz C, Rieder L, Grantzow R, von Schweinitz D, Kappler R, Berger M

A 3D tumor microenvironment regulates cell proliferation, peritoneal growth and expression patterns

Loessner D, Rockstroh A, Shokoohmand A, Holzapfel BM, Wagner F, Baldwin JG, Boxberg M, Schmalfeldt B, Lengyel E, Clements JA, Hutmacher DW

Recombinant Human Bone Morphogenetic Protein 7 Exerts Osteo-Catabolic Effects on Bone Grafts That Outweigh Its Osteo-Anabolic Capacity.

Lahr CA, Wagner F, Shafiee A, Rudert M, Hutmacher DW, Holzapfel BM

Team performance during postsurgical patient handovers in paediatric care.

Weigl M, Heinrich M, Keil J, Wermelt JZ, Bergmann F, Hubertus J, Hoffmann F

Long-Term Follow-Up Examination of the Internal Jugular Vein After Vessel-Sparing Implantation of a Hickman Catheter or Port Catheter.

Ritz LA, Ley-Zaporozhan J, von Schweinitz D, Hubertus J

Targeting excessive MYCN expression using MLN8237 and JQ1 impairs the growth of hepatoblastoma cells

Eberherr C, Beck A, Vokuhl C, Becker K, Häberle B, von Schweinitz D, Kappler R

Osteoclastic craniectomy for scaphocephaly in infants results in physiological head shapes.

Lehner M, Ferrari-von Klot F, Zundel S, Wendling-Keim D

Multidisziplinäre Langzeitbetreuung und zeitgemäße chirurgische Therapie kongenitaler melanozytärer Nävi - Empfehlungen des Netzwerks Nävuschirurgie.

Ott H, Krengel S, Beck O, Böhler K, Böttcher-Haberzeth S, Cangir Ö, Fattouh M, Häberle B, Hüging M, Königs I, Kosch F, Rok K, Marathovouniotis N, Meyer L, Neuhaus K, Rothe K, Schiestl C, Sinnig M, Theiler M, von der Heydt S, Wälchli R, Weibel L, Wendenburg W, Breuninger H

Vessel adherent growth represents a major challenge in the surgical resection of neuroblastoma and Is associated with adverse outcome.

Mühling J, Eberherr C, Müller Höcker J, Grote V, von Schweinitz D, Kappler R, Fröba-Pohl A

High Dose Chemotherapy with Autologous Stem Cell Transplantation in Hepatoblastoma does not Improve Outcome. Results of the GPOH Study HB99.

Häberle B, Maxwell R, Schweinitz DV, Schmid I

Patients under 4 years old treated with overhead extension for isolated femoral fractures - lessons learned concerning parents' satisfaction.

Wagner F, Schütz V, Hubertus J

Prognostic Factors for the Outcome of Supracondylar Humeral Fractures in Children.

Wendling-Keim DS, Binder M, Dietz HG, Lehner M

Smartphone-Related Accidents in Children and Adolescents: A Novel Mechanism of Injury.

Wagner R, Gosemann JH, Sorge I, Hubertus J, Lacher M, Mayer S

The treatment of elbow dislocations in children and adolescents : Consensus report of the pediatric trauma section of the German Trauma Society (DGU).

Bergmann F, Großer K, Lieber J

Reduction of treatment time for children in the trauma room care: Impact of implementation of an interdisciplinary trauma room concept (iTRAP).

Lehner M, Hoffmann F, Kammer B, Heinrich M, Falkenthal L, Wendling-Keim D, Kurz M

Humanization of bone and bone marrow in an orthotopic site reveals new potential therapeutic targets in osteosarcoma.

Wagner F, Holzapfel BM, McGovern JA, Shafiee A, Baldwin JG, Martine LC, Lahr CA, Wunner FM, Friis T, Bas O, Boxberg M, Prodinger PM, Shokoohmand A, Moi D, Mazzieri R, Loessner D, Hutmacher DW

Humanization of the Prostate Microenvironment Reduces Homing of PC3 Prostate Cancer Cells to Human Tissue-Engineered Bone.

McGovern JA, Shafiee A, Wagner F, Lahr CA, Landgraf M, Meinert C, Williams ED, Russell PJ, Clements JA, Loessner D, Holzapfel BM, Risbridger GP, Hutmacher DW

Overexpression of UHRF1 promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastoma.

Beck A, Trippel F, Wagner A, Joppien S, Felle M, Vokuhl C, Schwarzmayr T, Strom TM, von Schweinitz D, Längst G, Kappler R

Intuitive Visualization of Innervation Zones Based on Surface-EMG Signals.

Kiese C, Landgraf HP, Danzer AL, Schickling B, Nicolau-Torra A, Reitmeier T, Schulter-Mattler W, von Schweinitz D, Ketterl H

Immune system augmentation via humanization using stem/progenitor cells and bioengineering in a breast cancer model study.

Shafiee A, McGovern JA, Lahr CA, Meinert C, Moi D, Wagner F, Landgraf M, De-Juan-Pardo E, Mazzieri R, Hutmacher DW

MiR-492 regulates hepatoblastoma metastasis via CD44.

von Frowein J, Hauck S, Kappler R, Pagel P, Fleischmann K, Magg T, Cairo S, Roscher A, von Schweinitz D, Schmid I

The landscape of genomic alterations across childhood cancers.

Groebner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, Johann PD, Balasubramanian P, Segura-Wang M, Brabetz S, Bender S, Hutter B, Sturm D, Pfaff E, Hübschmann D, Zipprich G, Heinold M, Eils J, Lawerenz C, Erkek S, Lambo S, Waszak S, Blattmann C, Borkhardt A, Kuhlen M, Eggert A, Fulda S, Gessler M, Wegert J, Kappler R, Baumhoer D, Burdach S, Kirschner-Schwabe R, Kontny U, Kulozik A, Lohmann D, Hettmer S, Eckert C, Bielack S, Nathrath M, Niemeyer C, Richter G, Schulte J, Siebert R, Westermann F, Molenaar JJ, Vassal G, Witt H, ICGC MMML-Seq Project, Burkhardt B, Kratz CP, Witt O, van Tilburg C, Kramm C, Fleischhack G, Dirksen U, Rutkowski S, Frühwald M, von Hoff K, Wolf S, Klingebiel T, Koscielniak E, Landgraf P, Koster J, Resnick AC, Zhang J, Liu Y, Zhou X, Waanders AJ, Zwijnenburg DA, Raman P, Brors B, Weber U, Northcott PA, Pajtler KW, Kool M, Piro RM, Korbel JO, Schlesner M, Eils R, Jones DTW, Lichter P, Chavez L, Zapatka M, Pfister SM

High-dose treatment for malignant rhabdoid tumor of the kidney: No evidence for improved survival-The Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) experience.

Furtwängler R, Kager L, Melchior P, Rübe C, Ebinger M, Nourkami-Tutdibi N, Niggli F, Warmann S, Hubertus J, Amman G, Leuschner I, Vokuhl C, Graf N, Frühwald MC

Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options.

Schmid I, Klenk AK, Sparber-Sauer M, Koscielniak E, Maxwell R, Häberle B

Disease-specific Knowledge in Conservative Treatment of Adolescent Idiopathic Scoliosis.

Wagner F, Brendel J, Dingeldey E, Winkler S, Grifka J, Matussek J

Parents reported reduced symptoms and improved satisfaction after fundoplication and their perceptions were an important outcome measure.

Heinrich M, Kain A, Bergmann F, von Schweinitz D

Lycopene reduces ovarian tumor growth and intraperitoneal metastatic load.

Holzapfel NP, Shokoohmand A, Wagner F, Landgraf M, Champ S, Holzapfel BM, Clements JA, Hutmacher DW, Loessner D

Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.

Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, Debatin KM, Deubzer H, Dirksen U, Eckert C, Eggert A, Erlacher M, Fleischhack G, Frühwald MC, Gnekow A, Goehring G, Graf N, Hanenberg H, Hauer J, Hero B, Hettmer S, von Hoff K, Horstmann M, Hoyer J, Illig T, Kaatsch P, Kappler R, Kerl K, Klingebiel T, Kontny U, Kordes U, Körholz D, Koscielniak E, Kramm CM, Kuhlen M, Kulozik AE, Lamottke B, Leuschner I, Lohmann DR, Meinhardt A, Metzler M, Meyer LH, Moser O, Nathrath M, Niemeyer CM, Nustede R, Pajtler KW, Paret C, Rasche M, Reinhardt D, Rieß O, Russo A, Rutkowski S, Schlegelberger B, Schneider D, Schneppenheim R, Schrappe M, Schroeder C, von Schweinitz D, Simon T, Sparber-Sauer M, Spix C, Stanulla M, Steinemann D, Strahm B, Temming P, Thomay K, von Bueren AO, Vorwerk P, Witt O, Wlodarski M, Wössmann W, Zenker M, Zimmermann S, Pfister SM, Kratz CP

Therapeutic Innovations for Targeting Childhood Neuroblastoma: Implications of the Neurokinin-1 Receptor System.

Berger M, von Schweinitz D

Expression of Truncated Neurokinin-1 Receptor in Childhood Neuroblastoma is Independent of Tumor Biology and Stage.

Pohl A, Kappler R, Mühling J, von Schweinitz D, Berger M

Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months.

Fischer J, Pohl A, Volland R, Hero B, Dübbers M, Cernaianu G, Berthold F, von Schweinitz D, Simon T

Periosteum tissue engineering in an orthotopic in vivo platform.

Baldwin JG, Wagner F, Martine LC, Holzapfel BM, Theodoropoulos C, Bas O, Savi FM, Werner C, De-Juan-Pardo EM, Hutmacher DW

Transcriptional activation of Hedgehog pathway components in aggressive haemangioma.

Wendling-Keim DS, Wanie L, von Schweinitz D, Grantzow R, Kappler R

Evaluation of a Pilot Project to Introduce Simulation-Based Team Training to Pediatric Surgery Trauma Room Care.

Lehner M, Heimberg E, Hoffmann F, Heinzel O, Kirschner HJ, Heinrich M

Pediatric hepatocellular carcinoma: challenges and solutions.

Schmid I, von Schweinitz D

2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors.

Simon T, Hero B, Schulte JH, Deubzer H, Hundsdoerfer P, von Schweinitz D, Fuchs J, Schmidt M, Prasad V, Krug B, Timmermann B, Leuschner I, Fischer M, Langer T, Astrahantseff K, Berthold F, Lode H, Eggert A

Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.

Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T, Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P

Engineering a humanized bone organ model in mice to study bone metastases.

Martine LC, Holzapfel BM, McGovern JA, Wagner F, Quent VM, Hesami P, Wunner FM, Vaquette C, De-Juan-Pardo EM, Brown TD, Nowlan B, Wu DJ, Hutmacher CO, Moi D, Oussenko T, Piccinini E, Zandstra PW, Mazzieri R, Lévesque JP, Dalton PD, Taubenberger AV, Hutmacher DW

Ambulatory or inpatient management of mild TBI in children: a post-concussion analysis.

Wendling-Keim DS, König A, Dietz HG, Lehner M

Pediatric Emergency Appendectomy and 30-Day Postoperative Outcomes in District General Hospitals and Specialist Pediatric Surgical Centers in England, April 2001 to March 2012: Retrospective Cohort Study.

Giuliani S, Cecil EV, Apelt N, Sharland M, Saxena S

Therapeutic Innovations for Targeting Hepatoblastoma.

Garnier A, Ilmer M, Kappler R, Berger M

Treatment and outcome of Ganglioneuroma and Ganglioneuroblastoma intermixed.

Decarolis B, Simon T, Krug B, Leuschner I, Vokuhl C, Kaatsch P, von Schweinitz D, Klingebiel T, Mueller I, Schweigerer L, Berthold F, Hero B

Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastoma.

Beck A, Eberherr C, Hagemann M, Cairo S, Häberle B, Vokuhl C, von Schweinitz D, Kappler R

Tissue engineering and regenerative medicine in musculoskeletal oncology.

Holzapfel BM, Wagner F, Martine LC, Reppenhagen S, Rudert M, Schuetz M, Denham J, Schantz JT, Hutmacher DW

The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model.

Czauderna P, Haeberle B, Hiyama E, Rangaswami A, Krailo M, Maibach R, Rinaldi E, Feng Y, Aronson D, Malogolowkin M, Yoshimura K, Leuschner I, Lopez-Terrada D, Hishiki T, Perilongo G, von Schweinitz D, Schmid I, Watanabe K, Derosa M, Meyers R

Improving postoperative pain management in children by providing regular training and an updated pain therapy concept.

Heinrich M, Mechea A, Hoffmann F

Inflammatory pseudotumor (IPT)-surgical cure of an inflammatory syndrome.

Rack A, Belohradsky BH, Grantzow R, von Schweinitz D, Pfluger T, Kammer B, Girschick H, Horst D, Wintergerst U

Small cell undifferentiated (SCUD) hepatoblastomas: All malignant rhabdoid tumors?

Vokuhl C, Oyen F, Häberle B, von Schweinitz D, Schneppenheim R, Leuschner I

Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma.

Gödeke J, Luxenburger E, Trippel F, Becker K, Häberle B, Müller-Höcker J, von Schweinitz D, Kappler R

Patient-derived xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management.

Nicolle D, Fabre M, Simon-Coma M, Gorse A, Kappler R, Nonell L, Mallo M, Haidar H, Déas O, Mussini C, Guettier C, Redon MJ, Brugières L, Rosa Ghigna M, Fadel E, Galmiche-Rolland L, Chardot C, Judde JG, Armengol C, Branchereau S, Cairo S

A Validated Preclinical Animal Model for Primary Bone Tumor Research.

Wagner F, Holzapfel BM, Thibaudeau L, Straub M, Ling MT, Grifka J, Loessner D, Lévesque JP, Hutmacher DW

Assessment of Primary Site Response in Children With High-Risk Neuroblastoma: An International Multicenter Study.

Bagatell R, McHugh K, Naranjo A, Van Ryn C, Kirby C, Brock P, Lyons KA, States LJ, Rojas Y, Miller A, Volchenboum SL, Simon T, Krug B, Sarnacki S, Valteau-Couanet D, von Schweinitz D, Kammer B, Granata C, Pio L, Park JR, Nuchtern J

Communicating the Improvements Developed from Critical Incident Reports is an Essential Part of CIRS.

Hubertus J, Piehlmeier W, Heinrich M

Laparoscopic Adrenalectomy is Feasible for Suspected Adrenal Tumors in Children Younger than 24 Months of Age - But is it Always Justified?

Hubertus J, Pohl A, Schmid I, von Schweinitz D

Image-defined Risk Factors Correlate with Surgical Radicality and Local Recurrence in Patients with Neuroblastoma.

Pohl A, Erichsen M, Stehr M, Hubertus J, Bergmann F, Kammer B, von Schweinitz D

The Importance of Computed Tomography for the Diagnosis Of Duodenal Perforation in a Paediatric Patient with Juvenile Dermatomyositis.

Schneider KO, Braeuninger C, Bergmann F, Kammer B

Association of FOXM1 expression with tumor histology and prognosis in Wilms tumor: Potential for a new prognostic marker.

Apelt N, Hubertus J, Mayr D, Graf N, Furtwängler R, von Schweinitz D, Kappler R

Truncated neurokinin-1 receptor is an ubiquitous antitumor target in hepatoblastoma, and its expression is independent of tumor biology and stage.

Garnier A, Ilmer M, Becker K, Häberle B, von Schweinitz D, Kappler R, Berger M

γ-secretase inhibitor I inhibits neuroblastoma cells, with NOTCH and the proteasome among its targets.

Dorneburg C, Goß AV, Fischer M, Roels F, Barth TF, Berthold F, Kappler R, Oswald F, Siveke JT, Molenaar JJ, Debatin KM, Beltinger C

Activation of the Wnt/ß-catenin pathway is common in wilms tumor, but rarely through ß-catenin mutation and APC promoter methylation.

Schweigert A, Fischer C, Mayr D, von Schweinitz D, Kappler R, Hubertus J